Effects of spike protein and toxin-like peptides found in COVID-19

Toxic' spike protein claims misinterpret vaccine study – Australian Associated Press

Restoration of Brain Angiotensin-Converting Enzyme 2 Alleviates Neurological Deficits after Severe Traumatic Brain Injury via Mitigation of Pyroptosis and Apoptosis

Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses

Anatomy of a 'correlate of protection' for T-cell vaccines

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

JCI - Citations to SARS–CoV-2 infection of the placenta

Helena Martins Soares - Secretary General of the Board of Directors - Portuguese Society of Immunology

Effects of spike protein and toxin-like peptides found in COVID-19 patients on human 3D neuronal/glial model undergoing differentiation: Possible implications for SARS-CoV-2 impact on brain development - ScienceDirect

Human Immunobiology and Pathogenesis Laboratory - Helena Soares - Research Group

Human Immunobiology and Pathogenesis Laboratory - Helena Soares - Research Group

Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization - Computational and Structural Biotechnology Journal

Helena Martins Soares - Secretary General of the Board of Directors - Portuguese Society of Immunology

Full Programme European Society of Toxicology In Vitro

Loop Remo Sanges

Cholesterol 25‐Hydroxylase inhibits SARS‐CoV‐2 and other coronaviruses by depleting membrane cholesterol